IS5186A - Kínólín-2-karboxýlsýru afleiða og notkun hennar sem mótlyf fyrir örvandi amínósýrur - Google Patents
Kínólín-2-karboxýlsýru afleiða og notkun hennar sem mótlyf fyrir örvandi amínósýrurInfo
- Publication number
- IS5186A IS5186A IS5186A IS5186A IS5186A IS 5186 A IS5186 A IS 5186A IS 5186 A IS5186 A IS 5186A IS 5186 A IS5186 A IS 5186A IS 5186 A IS5186 A IS 5186A
- Authority
- IS
- Iceland
- Prior art keywords
- quinoline
- antagonists
- carboxylic acid
- amino acids
- acid derivative
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical class C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9706294.7A GB9706294D0 (en) | 1997-03-26 | 1997-03-26 | Heterocyclic compound |
| PCT/EP1998/001700 WO1998042673A1 (en) | 1997-03-26 | 1998-03-24 | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5186A true IS5186A (is) | 1999-09-17 |
Family
ID=10809909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5186A IS5186A (is) | 1997-03-26 | 1999-09-17 | Kínólín-2-karboxýlsýru afleiða og notkun hennar sem mótlyf fyrir örvandi amínósýrur |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0971896A1 (is) |
| JP (1) | JP2001518901A (is) |
| KR (1) | KR20010005567A (is) |
| CN (1) | CN1257482A (is) |
| AP (1) | AP9901659A0 (is) |
| AU (1) | AU731394B2 (is) |
| BR (1) | BR9808424A (is) |
| CA (1) | CA2284710A1 (is) |
| EA (1) | EA199900755A1 (is) |
| GB (1) | GB9706294D0 (is) |
| HU (1) | HUP0001661A3 (is) |
| ID (1) | ID24306A (is) |
| IL (1) | IL131919A0 (is) |
| IS (1) | IS5186A (is) |
| NO (1) | NO994679L (is) |
| NZ (1) | NZ337793A (is) |
| PL (1) | PL335865A1 (is) |
| TR (1) | TR199902315T2 (is) |
| WO (1) | WO1998042673A1 (is) |
| YU (1) | YU47699A (is) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
| DE10132725A1 (de) | 2001-07-05 | 2006-08-03 | Grünenthal GmbH | Substituierte γ-Lactonverbindungen |
| DE10137487A1 (de) * | 2001-08-03 | 2003-03-27 | Gruenenthal Gmbh | Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate |
| DE10306202A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| JP4360891B2 (ja) | 2003-12-09 | 2009-11-11 | アルパイン株式会社 | 放送受信機能を備えた電子装置およびその装置における電子番組ガイドの表示方法 |
| JP4754566B2 (ja) | 2005-07-22 | 2011-08-24 | 持田製薬株式会社 | 新規なヘテロシクリデンアセトアミド誘導体 |
| RU2451014C2 (ru) * | 2005-07-22 | 2012-05-20 | Мотида Фармасьютикал Ко., Лтд. | Новое производное гетероциклиден ацетамида |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| CN110996948A (zh) | 2017-06-12 | 2020-04-10 | 格莱泰施有限责任公司 | 用nmda拮抗剂和d2/5ht2a或选择性5ht2a拮抗剂治疗抑郁症 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE147732T1 (de) * | 1989-03-08 | 1997-02-15 | Merck Sharp & Dohme | Tetrahydroquinolin-derivate, verwendbar bei neurodegenerativen krankheiten |
| ATE221520T1 (de) * | 1995-09-29 | 2002-08-15 | Glaxo Wellcome Spa | Tetrahydrochinoline als nmda antagonisten |
| GB9617305D0 (en) * | 1996-08-17 | 1996-09-25 | Glaxo Wellcome Spa | Heterocyclic compounds |
-
1997
- 1997-03-26 GB GBGB9706294.7A patent/GB9706294D0/en active Pending
-
1998
- 1998-03-24 PL PL98335865A patent/PL335865A1/xx unknown
- 1998-03-24 CN CN98805302A patent/CN1257482A/zh active Pending
- 1998-03-24 TR TR1999/02315T patent/TR199902315T2/xx unknown
- 1998-03-24 EP EP98919133A patent/EP0971896A1/en not_active Withdrawn
- 1998-03-24 BR BR9808424-0A patent/BR9808424A/pt not_active IP Right Cessation
- 1998-03-24 IL IL13191998A patent/IL131919A0/xx unknown
- 1998-03-24 WO PCT/EP1998/001700 patent/WO1998042673A1/en not_active Ceased
- 1998-03-24 AP APAP/P/1999/001659A patent/AP9901659A0/en unknown
- 1998-03-24 YU YU47699A patent/YU47699A/sh unknown
- 1998-03-24 JP JP54323498A patent/JP2001518901A/ja active Pending
- 1998-03-24 CA CA002284710A patent/CA2284710A1/en not_active Abandoned
- 1998-03-24 ID IDW991108A patent/ID24306A/id unknown
- 1998-03-24 AU AU72094/98A patent/AU731394B2/en not_active Ceased
- 1998-03-24 HU HU0001661A patent/HUP0001661A3/hu unknown
- 1998-03-24 EA EA199900755A patent/EA199900755A1/ru unknown
- 1998-03-24 NZ NZ337793A patent/NZ337793A/en unknown
- 1998-03-24 KR KR1019997008630A patent/KR20010005567A/ko not_active Withdrawn
-
1999
- 1999-09-17 IS IS5186A patent/IS5186A/is unknown
- 1999-09-24 NO NO994679A patent/NO994679L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0001661A2 (hu) | 2000-09-28 |
| BR9808424A (pt) | 2000-05-23 |
| GB9706294D0 (en) | 1997-05-14 |
| NO994679L (no) | 1999-11-24 |
| IL131919A0 (en) | 2001-03-19 |
| YU47699A (sh) | 2001-12-26 |
| TR199902315T2 (xx) | 2000-05-22 |
| WO1998042673A1 (en) | 1998-10-01 |
| EA199900755A1 (ru) | 2000-08-28 |
| ID24306A (id) | 2000-07-13 |
| NO994679D0 (no) | 1999-09-24 |
| PL335865A1 (en) | 2000-05-22 |
| HUP0001661A3 (en) | 2001-12-28 |
| AU731394B2 (en) | 2001-03-29 |
| CA2284710A1 (en) | 1998-10-01 |
| AU7209498A (en) | 1998-10-20 |
| CN1257482A (zh) | 2000-06-21 |
| JP2001518901A (ja) | 2001-10-16 |
| AP9901659A0 (en) | 1999-09-30 |
| NZ337793A (en) | 2001-02-23 |
| EP0971896A1 (en) | 2000-01-19 |
| KR20010005567A (ko) | 2001-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0200297A3 (en) | Method for acylating peptides and the glutaminic acid derivatives as acylating agents | |
| EE200100649A (et) | A-beeta peptiidi kompositsioonid ja meetodid nende valmistamiseks | |
| ZA989740B (en) | Cyclic amino acids and derivatives thereof useful as pharmaceutical agents | |
| DE69813570D1 (de) | 5-alkyl-2-arylaminophenylessigsäure und derivative | |
| HUP9902136A3 (en) | Novel substituted cyclic amino acid derivatives use as pharmaceutical agents | |
| PL330482A1 (en) | Novel amino acid derivatives and their application as thrombosin inhibitors | |
| GB9623908D0 (en) | Amino acid derivatives | |
| GB9806815D0 (en) | Amino acid derivatives | |
| GB2351396B (en) | Method of connecting covered wires and recessed tip for use in the method | |
| SI1226110T1 (en) | Bicyclic amino acids as pharmaceutical agents | |
| PL344589A1 (en) | COMPOSITION COMPRISING β-HYDROXY-β-METHYLBUTYRIC ACID AND AT LEAST ONE AMINO ACID AND METHODS OF USE | |
| IS4862A (is) | Amínóísókínólín og amínóþíenópýridínafleiður og notkun þeirra sem bólgueyðandi efna | |
| NO993001D0 (no) | Farmas°ytiske aminofosfonsyrederivater | |
| HUP0003484A3 (en) | Pyrrolidine-3-crboxylic acid derivatives and their use as endothelin antagonists | |
| HUP9901630A3 (en) | Indole-2,3-dione-3-oxime derivatives as antagonists of excitatory amino acids, preparation and use thereof | |
| IL131919A0 (en) | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist | |
| FI990973A7 (fi) | Harvesteripää ja menetelmä siinä | |
| EE200200353A (et) | Inimese heparanaasisarnane polüpeptiid ja nukleiinhape | |
| HK1022900A (en) | Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist | |
| ZA985940B (en) | Amino acid derivatives | |
| FI973647L (fi) | Hydroksihappo-, dikarboksyylihappo- ja aminohappoesterit ja niiden käyttö | |
| GB9920899D0 (en) | Amino acid transporter protein | |
| SI0888286T1 (en) | Novel substituted cyclic amino acids as pharmaceutical agents |